Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Studies shed light on pain perception, placebo effect pathways, and how human stem cells can be used to model pain ... Aside from the challenges of beating the placebo effect, drugs do not always work ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.